Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: J Thorac Oncol. 2016 Jan;11(1):52–61. doi: 10.1016/j.jtho.2015.09.015

Table 2.

List of 30 Candidate Deleterious Germline Mutations in Familial and Sporadic LC Cases

Region Disease
association
Gene Marker * SNV/Indels Ref./Alt. RS ID MAF in KG/ESP CADD
C-score #
N mutated Familial
vs. Sporadic
Total N mutated
LC cases
10q25.1 LC+SM+PF CCDC147 10:106163533-SNV p.Arg696Cys C/T rs41291850 0.0026/0.0072 16.2 2 : 1 3

9q34.2 SM DBH 9:136501569-SNV p.Val26Met G/A rs76856960 0.0034/0.0045 17.3 0 : 2 & 3
9:136522317-SNV p.Met563Thr T/C rs201973877 0.0002/0.0002 20.3 1 : 0

15q25.1 LC+SM+PF+COPD IREB2 15:78783019-SNV p.Gly747Glu G/A rs139092247 0.0014/0.0034 35 1 : 0 3
CHRNA5 15:78880766-SNV g. splice donor G/A rs200616965 NA 22.7 0 : 1 & a
CHRNB4 15:78921343-SNV p.Ala435Val G/A rs56317523 0.0008/0.0028 27.2 1 : 0

16q23.1 PF KARS 16:75665388-SNV p.Arg421Gln C/T rs149772470 0.0002/0.0018 26.1 0 : 1 & 3
16:75665146-SNV p.Arg448Cys G/A rs77573084 0.0006/0.0030 19.6 0 : 1 & a
WWOX 16:78466521-SNV p.Arg310Cys C/T rs193001955 0.0006/0.0006 24.1 0 : 1 &

1q44 SM C1orf100 1:244541827-SNV p.Asp71His G/C rs41269385 0.0022/0.0065 14.2 2 : 0 2

2q35 PF TNS1 2:218686643-SNV p.Glu1027Val T/A rs112371945 0.0006/0.0013 22.7 1 : 0 2
2:218669288-SNV p.Thr1701Met G/A rs61740054 0.0010/0.0034 27.9 0 : 1 &

5q32 LC+PF FBXO38 5:147817940-SNV p.Pro893Arg C/G rs141168806 NA/0.0001 22.9 1 : 0 2
5:147821690-SNV p.Val1108Ile G/A rs143682696 0.0002/0.0008 26.4 1 : 0

7q31.1 SM PNPLA8 7:108154659-SNV p.Cys379Gly A/C rs141089628 0.0002/0.0033 15.1 0 : 1 & 2
7:108137944-SNV p.Ile479Ser A/C Novel NA 25.2 1 : 0

10q23.31 LC+SM+COPD PANK1 10:91359156-SNV p.Phe163Ser A/G Novel NA 26.1 1 : 0 2
IDE 10:94243061-SNV p.Asp9Asn C/T Novel NA 36 0 : 1 & b

13q12.12 LC MIPEP 13:24448998-SNV p.Leu197Pro A/G rs150167906 0.0002/0.0023 21.4 1 : 1 2

14q22.1 PF NID2 14:52508948-SNV p.Thr567Met G/A rs150406341 0.0006/0.0060 19.3 1 c : 1 & a 2

17q24.2 LC+PF BPTF 17:65889520-SNV p.Arg823Gln G/A rs375975293 NA/0.0001 19.8 1 : 0 2
17:65936627-SNV p.Thr2237Met C/T rs372551122 NA 17.2 0 : 1 &

5q33.1 LC+PF MYOZ3 5:150051315-SNV g. splice acceptor A/G rs143036945 0.0002/0.0005 12.3 0 : 1 1

10q22.2–3 PF C10orf11 10:77542754-Deletion p.Ser8 Frameshift C/− rs146123023 0.007/0.0013 NA 1 : 0 1

12q13.3 PF LRP1 12:57577915-SNV p.Arg1993Trp C/T rs141826184 0.0004/0.0031 21.8 0 : 1 & 1

12q21.2 SM NAV3 12:78392209-SNV p.Ser278Ile G/T rs755721519 NA 31 0 : 1 & b 1

14q24.2 PF SLC8A3 14:70515508-SNV p.Val152Met C/T rs144289733 0.0004/0.0008 27 1 : 0 1

15q15.2 LC TGM5 15:43527092-SNV p.Tyr502His A/G rs146901531 0.0002/0.0006 18.8 0 : 1 & 1

18p11.3 LC LAMA1 18:6965341-SNV p.Arg2381Cys G/A rs142063208 0.0028/0.0016 25 1 c : 0 1

19q13.2 LC+SM+PF+COPD EGLN2 19:41307024-SNV p.Val183Met G/A rs117916638 0.0002/0.0004 16.9 1 : 0 1
*

All are heterozygous mutations.

#

C-score is the overall measure of deleteriousness. C-score ≥ 20 indicates top 1% deleterious in the human genome.

&

Sporadic LC patient(s) with severe COPD;

a,b,c

Indicates the same patients.